Cardiovascular effects of GLP-1 RAs have been of great interest since the burden from cardiovascular diseases (CVD) has been unbearably increasing in a diabetic population worldwide, despite strict glycemic control and advanced therapeutic techniques to treat CVD
Schedule a Complimentary Consultation Visit Us Online Related Resources Employee Benefits Solutions Group Health Insurance Level-Funded Health Plans Corporate Wellness HR & Employee Benefits Blog YouTube Channel
10.1038/s41586-019-1705-2 5 BesserE.GelfandA.ProcacciaS.BermanP.MeiriD
The Numbers Behind Blood Pressure Reduction When researchers combine results from many studies, they find that GLP-1 medications lower systolic blood pressure (the top number) by: 2 to 6 mmHg on average when compared to placebo Semaglutide: about 3 to 5 mmHg reduction Liraglutide: about 2.5 to 3 mmHg reduction Tirzepatide: about 7 to 11 mmHg reduction (the most powerful) These numbers might seem small, but they matter
Research has shown that increasing the energy available to the cells helps the body operate at its optimum level
How do I adjust the vitamin B12 injection dosage for special conditions, such as renal impairment or malabsorption disorders